Evidence map›Paper›PMID 21576321›Full record

ArticleInfection and immunity2011

Requirement for invariant chain in macrophages for Mycobacterium tuberculosis replication and CD1d antigen presentation.

Fenna C M Sillé, Constance Martin, Pushpa Jayaraman, Alissa Rothchild, Sarah Fortune, Gurdyal S Besra, Samuel M Behar, Marianne Boes

Abstract read
In one paragraph

Article in Infection and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. iScience · 2026
    Article
  2. Role of MHC class I pathways inFrontiers in cellular and infection microbiology · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fenna C M SilléDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Constance Martin
Pushpa Jayaraman
Alissa Rothchild
Sarah Fortune
Gurdyal S Besra
Samuel M Behar
Marianne Boes

Funding

Cd1d regulation and its effect on NKT cell activationR01HL080330 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BEHAR, SAMUEL M · 2006 to 2010
$2.5M
Treatment of tuberculosis with immunomodulatorsR01HL080312 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BEHAR, SAMUEL M · 2004 to 2008
$1.9M
Class II MHC & CD1d antigen presentation pathways in skin-derived dendritic cellsR01AR052810 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI FUHLBRIGGE, ROBERT C · 2007 to 2011
$1.0M
NHLBI NIH HHS 5 R01 HL080330NHLBI NIH HHS R01 HL080312NHLBI NIH HHS R01 HL080330NIAMS NIH HHS R01 AR052810NIAMS NIH HHS R01-AR052810
6 · The paper itself

Abstract

Mycobacterium tuberculosis is an intracellular bacterium that persists in phagosomes of myeloid cells. M. tuberculosis-encoded factors support pathogen survival and reduce fusion of phagosomes with bactericidal lysosomal compartments. It is, however, not entirely understood if host factors that mediate endosomal fusion affect M. tuberculosis intracellular localization and survival. Neither is it known if endosomal fusion influences induction of host immune reactivity by M. tuberculosis-infected cells. Lysosomal degradation of M. tuberculosis appears to be pivotal for making available lipid substrates for assembly into lipid-CD1d complexes to allow activation of CD1d-restricted invariant natural killer T (iNKT) cells. To clarify the role for endosomal fusion in M. tuberculosis survival and induction of host CD1d-mediated immune defense, we focused our studies on the invariant chain (Ii). Ii regulates endosome docking and fusion and thereby controls endosomal transport. Through direct binding, Ii also directs intracellular transport of the class II major histocompatibility complex and CD1d. Our findings demonstrate that upon infection of Ii-knockout (Ii(-/-)) macrophages, M. tuberculosis is initially retained in early endosomal antigen 1-positive lysosomal-associated membrane protein 1-negative phagosomes, which results in slightly impaired pathogen replication. The absence of Ii did not affect the ability of uninfected and infected macrophages to produce nitric oxide, tumor necrosis factor alpha, or interleukin-12. However, induction of cell surface CD1d was impaired in infected Ii(-/-) macrophages, and CD1d-restricted iNKT cells were unable to suppress bacterial replication when they were cocultured with M. tuberculosis-infected Ii(-/-) macrophages. Thus, while the host factor Ii is not essential for the formation of the M. tuberculosis-containing vacuole, its presence is crucial for iNKT cell recognition of infected macrophages.

Indexed as

Antigen PresentationAnimalsAntigens, CD1dAntigens, Differentiation, B-LymphocyteEndosomesGene DeletionHistocompatibility Antigens Class IIInterleukin-12Killer Cells, NaturalMacrophagesMiceMice, Inbred C57BLMice, KnockoutMicrobial ViabilityMycobacterium tuberculosisNitric OxideAntigens, CD1dAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIInterleukin-12invariant chainNitric OxideTumor Necrosis Factor-alpha

Identifiers

PMID21576321
PMCPMC3147586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.